Pilot Study of AuroLase(tm) Therapy in Refractory and/or Recurrent Tumors of the Head and Neck

This study is currently recruiting participants.
Verified January 2013 by Nanospectra Biosciences, Inc.
Sponsor:
Information provided by (Responsible Party):
Nanospectra Biosciences, Inc.
ClinicalTrials.gov Identifier:
NCT00848042
First received: February 19, 2009
Last updated: January 3, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)